Cure My Disease

Don't miss your cure!

Log in / Sign up

Macular telangiectasia

MONDO:1010184

An eye disorder characterized by retinal capillary network incompetence, dilatations, and thinning which can be uniocular or binocular and causes gradual deterioration of central vision.

4 clinical trials for this condition and its sub-types, 1 tagged with Macular telangiectasia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Eye disorder (3079)

Sub-types of Macular telangiectasia

Including sub-types (4) Tagged with Macular telangiectasia (1)

Eye drug trial for rare macular disease stops early – only 16 patients enrolled

Disease control Stopped early

This phase 3 trial tested aflibercept (Eylea) eye injections against placebo in 16 people with macular telangiectasia type 1, a rare condition that causes vision loss. The study aimed to see if aflibercept could reduce swelling in the macula. However, the trial was terminated ear…

Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC